We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Glenmark’s Generic Contraceptive Receives FDA Marketing Approval
Glenmark’s Generic Contraceptive Receives FDA Marketing Approval
April 30, 2010
Glenmark Generics has received FDA approval of a generic formulation of Watson Laboratories’ Nor-QD oral contraceptive.